Terns Pharmaceuticals, Inc. (TERN)
41.50
-0.02
(-0.05%)
USD |
NASDAQ |
Dec 29, 16:00
41.49
-0.01
(-0.02%)
After-Hours: 20:00
Terns Pharmaceuticals Shareholders Equity (Quarterly): 284.07M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Altimmune, Inc. | 185.60M |
| Ligand Pharmaceuticals, Inc. | 950.17M |
| ADMA Biologics, Inc. | 431.19M |
| Viking Therapeutics, Inc. | 713.03M |
| Cidara Therapeutics, Inc. | 422.39M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 301.65M |
| Total Liabilities (Quarterly) | 17.58M |
| Debt to Equity Ratio | 0.0036 |
| Current Ratio | 19.52 |
| Net Debt Paydown Yield | -0.02% |